User:SDZeroBot/NPP sorting/STEM/Chemistry: Difference between revisions

Content deleted Content added
SDZeroBot (talk | contribs)
Updating report
SDZeroBot (talk | contribs)
Updating report
Line 1:
{{User:SDZeroBot/NPP sorting/header|count=20|date=3031 August 2025|ts=1301:4746, 3031 August 2025 (UTC)}}
 
{| class="wikitable sortable"
Line 105:
| Jens Bruun de Neergaard (14 June 1742 – 22 April 1788) was a [[Denmark|Danish]] judge and landowner. He owned [[Svenstrup (manor house)|Svenstrup Manor]], at [[Borup, Køge|Broup]], [[Køge Municipality]], whouse present main building he constructed in the 1780s. On 31 May 1780, alongside his younger brother, Johan Thomas de Neergaard (1745–1806), he was ennobled by [[letters patent]].
| Start
| data-sort-value=8816488166 | [[Special:Contribs/Ramblersen2|Ramblersen2]] (8816488166)
|
|-
Line 112:
| The Hellenic Championship is an [[ATP 250 tournaments|ATP 250 tournament]] held in [[Athens]], [[Greece]]. The event is played on indoor [[hardcourt]] at the [[OAKA Basketball Arena]], a multi-purpose venue that was used for the [[2004 Summer Olympics]]. It replaces the [[Belgrade Open]] on the calendar and it is scheduled to debut in November 2025.
| Stub
| data-sort-value=40194021 | [[Special:Contribs/Haddad Maia fan|Haddad Maia fan]] (40194021)
|
|-
| 2025-05-04
| [[Erythrocyte-based drug delivery]] <small>(Drug delivery method)</small>
| Erythrocyte-based drug delivery systems (EBDDS) use [[red blood cells]], their membranes, or their components to release and deliver pharmaceutical agents throughout the body in a controlled manner. Because red blood cells circulate for long periods of time and are potentially non-[[immunogenic]], they are an attractive vector for [[drug delivery]] via the circulatory system.
| C
| data-sort-value=6 | [[Special:Contribs/DrugDelivery2025|DrugDelivery2025]] (6)
|
|-
Line 141 ⟶ 134:
| Stub
| data-sort-value=24 | [[Special:Contribs/Wang Walton|Wang Walton]] (24)
|
|-
| 2025-05-04
| [[Erythrocyte-based drug delivery]] <small>(Drug delivery method)</small>
| Erythrocyte-based drug delivery systems (EBDDS) use [[red blood cells]], their membranes, or their components to release and deliver pharmaceutical agents throughout the body in a controlled manner. Because red blood cells circulate for long periods of time and are potentially non-[[immunogenic]], they are an attractive vector for [[drug delivery]] via the circulatory system.
| C
| data-sort-value=6 | [[Special:Contribs/DrugDelivery2025|DrugDelivery2025]] (6)
|
|-
| 2004-07-29
| [[Figure of Insensitivity]]
| Figure of Insensitivity (''F of I'') is an inverse scale of measure of the impact [[shock sensitivity|sensitivity]] of an [[explosive]] substance. In this particular context the term 'Insensitivity' refers to the likelihood of initiation/[[detonation]] by impact, [[friction]], [[electrostatic discharge]], application of [[flame]], etc.
| Start
| data-sort-value=0 | [[Special:Contribs/20.133.0.11|20.133.0.11]]
|
|}
<span style="font-style: italic; font-size: 85%;">Last updated by [[User:SDZeroBot|SDZeroBot]] <sup>''[[User:SD0001|operator]] / [[User talk:SD0001|talk]]''</sup> at 1301:4746, 3031 August 2025 (UTC)</span>